Angiotensin II: A regulator of cardiomyocyte function and survival

Frontiers in Bioscience

Volumn 14, Issue 13, 2009, Pages 5118-5133

  Palomeque, Julieta ^a   Delbridge, Leanne ^b   Vila Petroff, Martin ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Apoptosis; Calcium; CamKII; MAPK; Myocardium; Myofilament responsiveness; Review; ROS

Indexed keywords

ANGIOTENSIN II; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CALCIUM SIGNALING; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CALCIUM SIGNALING; CELL SURVIVAL; HEART FAILURE; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 69149102427     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3590     Document Type: Article

References (148)

1. Braun-Menendez, E., J. C. Fasciolo, L. F. Leloir & J. M. Munoz: The substance causing renal hypertension. J Physiol, 98, 283-98(1940)
2. Page IH, H. O.: Acrystalline pressor substance (angiotonin) resulting from the reaction between renin and renin activator. J. Exp. Med., 15, 693-698(1940)
3. Mattiazzi, A.: Positive inotropic effect of angiotensin II. Increases in intracellular Ca2+ or changes in myofilament Ca2+ responsiveness? J Pharmacol Toxicol Methods, 37, 205-14(1997) (Pubitemid 27380388)
4. Timmermans, P. B., P. C. Wong, A. T. Chiu, W. F. Herblin, P. Benfield, D. J. Carini, R. J. Lee, R. R. Wexler, J. A. Saye & R. D. Smith: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev, 45, 205-51(1993) (Pubitemid 23191415)
5. Sadoshima, J. & S. Izumo: Molecular characterization of angiotensin II - induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res, 73, 413-23(1993) (Pubitemid 23238726)
6. Sadoshima, J. & S. Izumo: Signal transduction pathways of angiotensin II - induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res, 73, 424-38(1993) (Pubitemid 23238727)
7. De Mello, W. C. & A. H. Danser: Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension, 35, 1183-8(2000) (Pubitemid 30413647)
8. Aceto, J. F. & K. M. Baker: [Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol, 258, H806-13 (1990) (Pubitemid 20103214)
9. Kent, R. L. & P. J. McDermott: Passive load and angiotensin II evoke differential responses of gene expression and protein synthesis in cardiac myocytes. Circ Res, 78, 829-38(1996) (Pubitemid 26131367)
10. Schunkert, H. & B. H. Lorell: Role of angiotensin II in the transition of left ventricular hypertrophy to cardiac failure. Heart Failure 10, 142-149(1994) (Pubitemid 24296244)
11. Schunkert, H., J. Sadoshima, T. Cornelius, Y. Kagaya, E. O. Weinberg, S. Izumo, G. Riegger & B. H. Lorell: Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res, 76, 489-97(1995)
12. Dinh, D. T., A. G. Frauman, C. I. Johnston & M. E. Fabiani: Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond), 100, 481-92(2001) (Pubitemid 32434113)
13. Dorn, G. W., 2nd & T. Force: Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest, 115, 527-37(2005) (Pubitemid 40322222)
14. Mehta, P. K. & K. K. Griendling: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol, 292, C82-97 (2007) (Pubitemid 46127306)
15. Wu, L., M. Iwai, H. Nakagami, R. Chen, J. Suzuki, M. Akishita, M. de Gasparo & M. Horiuchi: Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol, 22, 49-54(2002) (Pubitemid 34076231)
16. Griffin, S. A., W. C. Brown, F. MacPherson, J. C. McGrath, V. G. Wilson, N. Korsgaard, M. J. Mulvany & A. F. Lever: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension, 17, 626-35(1991)
17. Kim, S., K. Ohta, A. Hamaguchi, T. Yukimura, K. Miura & H. Iwao: Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension, 25, 1252-9(1995)
18. Reudelhuber, T. L., K. E. Bernstein & P. Delafontaine: Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension, 49, 1196-201(2007) (Pubitemid 46809352)
19. Harrap, S. B., A. F. Dominiczak, R. Fraser, A. F. Lever, J. J. Morton, C. J. Foy & G. C. Watt: Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation, 93, 1148-54(1996) (Pubitemid 26087018)
20. Zhang, X., D. E. Dostal, K. Reiss, W. Cheng, J. Kajstura, P. Li, H. Huang, E. H. Sonnenblick, L. G. Meggs, K. M. Baker & et al.: Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am J Physiol, 269, H1791-802 (1995) (Pubitemid 3005975)
21. Danser, A. H., J. P. van Kats, P. J. Admiraal, F. H. Derkx, J. M. Lamers, P. D. Verdouw, P. R. Saxena & M. A. Schalekamp: Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension, 24, 37-48(1994) (Pubitemid 24195402)
22. Pieruzzi, F., Z. A. Abassi & H. R. Keiser: Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation, 92, 3105-12(1995)
23. Domenighetti, A. A., Q. Wang, M. Egger, S. M. Richards, T. Pedrazzini & L. M. Delbridge: Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension, 46, 426-32(2005) (Pubitemid 41099180)
24. Baker, K. M. & J. A. Aceto: Characterization of avian angiotensin II cardiac receptors: coupling to mechanical activity and phosphoinositide metabolism. J Mol Cell Cardiol, 21, 375-82(1989) (Pubitemid 19155233)
25. Capasso, J. M., P. Li, X. Zhang, L. G. Meggs & P. Anversa: Alterations in ANG II responsiveness in left and right myocardium after infarction-induced heart failure in rats. Am J Physiol, 264, H2056-67 (1993) doi not found. (Pubitemid 23205977)
26. Drimal, J. & D. Boska: Effects of angiotensin-II on myocardial mechanics and contractile state of heart muscle. Eur J Pharmacol, 21, 130-8(1973)
27. Ikenouchi, H., W. H. Barry, J. H. Bridge, E. O. Weinberg, C. S. Apstein & B. H. Lorell: Effects of angiotensin II on intracellular Ca2+ and pH in isolated beating rabbit hearts and myocytes loaded with the indicator indo-1. J Physiol, 480(Pt 2), 203-15(1994) (Pubitemid 24340927)
28. Ishihata, A. & M. Endoh: Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis. Br J Pharmacol, 114, 447-53(1995)
29. Kass, R. S. & M. L. Blair: Effects of angiotensin II on membrane current in cardiac Purkinje fibers. J Mol Cell Cardiol, 13, 797-809(1981) (Pubitemid 12198469)
30. Koch-Weser, J.: Nature of the Inotropic Action of Angiotensin on Ventricular Myocardium. Circ Res, 16, 230-7(1965)
31. Lefroy, D. C., T. Crake, F. del Monte, G. Vescovo, L. Dalla Libera, S. Harding & P. A. Poole-Wilson: Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol, 270, H2060-9 (1996) doi not found.
32. Moravec, C. S., M. D. Schluchter, L. Paranandi, B. Czerska, R. W. Stewart, E. Rosenkranz & M. Bond: Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation, 82, 1973-84(1990)
33. Palomeque, J., L. Sapia, R. J. Hajjar, A. Mattiazzi & M. Vila Petroff: Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. Am J Physiol Heart Circ Physiol, 290, H96-106 (2006)
34. Salas, M. A., M. G. Vila-Petroff, J. Palomeque, E. A. Aiello & A. Mattiazzi: Positive inotropic and negative lusitropic effect of angiotensin II: intracellular mechanisms and second messengers. J Mol Cell Cardiol, 33, 1957-71(2001) (Pubitemid 33097275)
35. Vila Petroff, M. G., E. A. Aiello, J. Palomeque, M. A. Salas & A. Mattiazzi: Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium. J Physiol, 529 Pt 1, 189-203(2000)
36. Li, P., E. H. Sonnenblick, P. Anversa & J. M. Capasso: Length-dependent modulation of ANG II inotropism in rat myocardium: effects of myocardial infarction. Am J Physiol, 266, H779-86 (1994)
37. Peach, M. J.: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev, 57, 313-70(1977) (Pubitemid 8097628)
38. Dudley, D. T., R. L. Panek, T. C. Major, G. H. Lu, R. F. Bruns, B. A. Klinkefus, J. C. Hodges & R. E. Weishaar: Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol, 38, 370-7(1990) (Pubitemid 20291576)
39. Whitebread S, M. M., Kember B, de Gasparo M.: Preliminary biochemcal characterization of two angiotensin II reseptor subtypes. Biochem. Biophis. Res. Commun., 163, 286-291(1989)
40. Chang RS, L. V.: Angiotensin reseptor subtypes in rat, rabbit and monkey tissues: relative distribution an speies dependency. Life Sci., 49, 1485-1490(1991)
41. Rogg H, S. A., de Gasparo M.: Identification and characterization of angiotensin II reseptor subtypes in rabbit ventricular myocardium. Biochem. Biophis. Res. Commun., 173, 416-422(1990)
42. Sechi LA, G. C., Grady EF, Kalinyak, Schambelan M.: Characterization of angiotensin II reseptor subtypes in rat heart. Circ Res, 71, 1482-1489(1992)
43. Nozawa Y, H. A., Oda N, Yamasaki Y, Matsuura N, Yamada S., Inabe K, Kimura R, Suzuki H, Hoshino T.: Angiotensin II reseptor subtypes in bovine and human ventricular myocardium. J. Pharmacol. Exp. Ther., 270, 566-571(1994) (Pubitemid 24271367)
44. Brink M, E. P., de Gasparo M, Rogg H, Schmid A, Stulz P, Bullock G.: Localization of the angiotensin II reseptor subtypes in human atrium. J. Mol. Cell. Cardiol., 28, 1789-1799(1996) (Pubitemid 26300578)
45. Tsutsumi, Y., H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, Y. Shibasaki, H. Kamihata, M. Inada & T. Iwasaka: Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res, 83, 1035-46(1998) (Pubitemid 28520933)
46. Wang, L., M. Eberhard, E. Kohler & P. Erne: A specific binding site for angiotensin II (3-8), angiotensin IV, in rabbit cardiac fibroblasts. J Recept Signal Transduct Res, 15, 517-27(1995)
47. Hanesworth, J. M., M. F. Sardinia, L. T. Krebs, K. L. Hall & J. W. Harding: Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther, 266, 1036-42(1993) (Pubitemid 23318723)
48. Ishihata, A. & M. Endoh: Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium. Br J Pharmacol, 108, 999-1005(1993) (Pubitemid 23102219)
49. Mattiazzi, A., N. G. Perez, M. G. Vila-Petroff, B. Alvarez, M. C. Camilion de Hurtado & H. E. Cingolani: Dissociation between positive inotropic and alkalinizing effects of angiotensin II in feline myocardium. Am J Physiol, 272, H1131-6 (1997)
50. Scott, A. L., R. S. Chang, V. J. Lotti & P. K. Siegl: Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart. J Pharmacol Exp Ther, 261, 931-5(1992)
51. Nakayama, M., X. Yan, R. L. Price, T. K. Borg, K. Ito, A. Sanbe, J. Robbins & B. H. Lorell: Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction. Am J Physiol Heart Circ Physiol, 288, H317-27 (2005) (Pubitemid 40023862)
52. Castro-Chaves, P., S. Soares, R. Fontes-Carvalho & A. F. Leite-Moreira: Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium. Eur J Pharmacol, 578, 261-9(2008)
53. Fujita, S. & M. Endoh: Influence of a Na+-H+ exchange inhibitor ethylisopropylamiloride, a Na+-Ca2+ exchange inhibitor KB-R7943 and their combination on the increases in contractility and Ca2+ transient induced by angiotensin II in isolated adult rabbit ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol, 360, 575-84(1999)
54. Meissner, A., J. Y. Min & R. Simon: Effects of angiotensin II on inotropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium. J Mol Cell Cardiol, 30, 2507-18(1998) (Pubitemid 28550000)
55. Rosenkranz, S., G. Nickenig, M. Flesch, B. Cremers, P. Schnabel, O. Lenz, T. Krause, D. Ganten, S. Hoffmann & M. Bohm: Cardiac angiotensin II receptors: studies on functional coupling in Sprague-Dawley rats and TGR (alphaMHC-hAT1) transgenic rats. Eur J Pharmacol, 330, 35-46(1997) (Pubitemid 27304032)
56. Sakurai, K., I. Norota, H. Tanaka, I. Kubota, H. Tomoike & M. Endo: Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sci, 70, 1173-84(2002) (Pubitemid 34137085)
57. Coats, A. J. & S. Adamopoulos: Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure. Cardiovasc Drugs Ther, 8, 685-92(1994) (Pubitemid 24376748)
58. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) The CONSENSUS Trial Study Group. N Engl J Med, 316, 1429-35(1987)
59. Mufti, S., S. Wenzel, G. Euler, H. M. Piper & K. D. Schluter: Angiotensin II-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect. J Cell Physiol, 217, 242-9(2008)
60. Fabiato, A.: Two kinds of calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cardiac cells. Adv Exp Med Biol, 311, 245-62(1992)
61. Kentish, J. C., R. J. Barsotti, T. J. Lea, I. P. Mulligan, J. R. Patel & M. A. Ferenczi: Calcium release from cardiac sarcoplasmic reticulum induced by photorelease of calcium or Ins (1, 4, 5) P3. Am J Physiol, 258, H610-5 (1990) doi not found. (Pubitemid 20103188)
62. Movsesian, M. A., A. P. Thomas, M. Selak & J. R. Williamson: Inositol trisphosphate does not release Ca2+ from permeabilized cardiac myocytes and sarcoplasmic reticulum. FEBS Lett, 185, 328-32(1985) (Pubitemid 15068063)
63. Vites, A. M. & A. Pappano: Inositol 1, 4, 5-trisphosphate releases intracellular Ca2+ in permeabilized chick atria. Am J Physiol, 258, H1745-52 (1990) (Pubitemid 20226309)
64. Anand-Srivastava, M. B.: Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein. Biochem Pharmacol, 38, 489-96(1989) (Pubitemid 19044238)
65. Kamp TJ, H. J.: Regulation of cardiac L-type calcium cahnnels by protein kinase A and protein kinase C. C. Circ Res., 87, 1095-1002(2000)
66. Kandasamy, R. A., F. H. Yu, R. Harris, A. Boucher, J. W. Hanrahan & J. Orlowski: Plasma membrane Na+/H+ exchanger isoforms (NHE-1,-2, and-3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways. J Biol Chem, 270, 29209-16(1995)
67. Moolenaar, W. H., L. G. Tertoolen & S. W. de Laat: Phorbol ester and diacylglycerol mimic growth factors in raising cytoplasmic pH. Nature, 312, 371-4(1984) (Pubitemid 15209315)
68. Wiederkehr, M. R., H. Zhao & O. W. Moe: Acute regulation of Na/H exchanger NHE3 activity by protein kinase C: role of NHE3 phosphorylation. Am J Physiol, 276, C1205-17 (1999) (Pubitemid 29244676)
69. Iwamoto, T., Y. Pan, S. Wakabayashi, T. Imagawa, H. I. Yamanaka & M. Shigekawa: Phosphorylationdependent regulation of cardiac Na+/Ca2+ exchanger via protein kinase C. J Biol Chem, 271, 13609-15(1996)
70. Wang, G., J. Anrather, M. J. Glass, M. J. Tarsitano, P. Zhou, K. A. Frys, V. M. Pickel & C. Iadecola: Nox2, Ca2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius. Hypertension, 48, 482-9(2006) (Pubitemid 44253744)
71. Wenzel, S., G. Taimor, H. M. Piper & K. D. Schluter: Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. Faseb J, 15, 2291-3(2001)
72. Clement, O., M. Puceat, M. P. Walsh & G. Vassort: Protein kinase C enhances myosin light-chain kinase effects on force development and ATPase activity in rat single skinned cardiac cells. Biochem J, 285(Pt 1), 311-7(1992)
73. Venema, R. C. & J. F. Kuo: Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J Biol Chem, 268, 2705-11(1993) (Pubitemid 23057899)
74. Barry, W. H., H. Matsui, J. H. Bridge & K. W. Spitzer: Excitation-contraction coupling in ventricular myocytes: effects of angiotensin II. Adv Exp Med Biol, 382, 31-9(1995)
75. Skolnick, R. L., S. E. Litwin, W. H. Barry & K. W. Spitzer: Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts. Am J Physiol, 275, H1788-97 (1998)
76. Watanabe, A. & M. Endoh: Relationship between the increase in Ca2+ transient and contractile force induced by angiotensin II in aequorin-loaded rabbit ventricular myocardium. Cardiovasc Res, 37, 524-31(1998) (Pubitemid 28166011)
77. Allen, I. S., N. M. Cohen, R. S. Dhallan, S. T. Gaa, W. J. Lederer & T. B. Rogers: Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms. Circ Res, 62, 524-34(1988) (Pubitemid 18078692)
78. Kaibara, M., S. Mitarai, K. Yano & M. Kameyama: Involvement of Na (+)-H+ antiporter in regulation of L-type Ca2+ channel current by angiotensin II in rabbit ventricular myocytes. Circ Res, 75, 1121-5(1994)
79. Aiello, E. A. & H. E. Cingolani: Angiotensin II stimulates cardiac L-type Ca (2+) current by a Ca (2+) - and protein kinase C-dependent mechanism. Am J Physiol Heart Circ Physiol, 280, H1528-36 (2001)
80. Ichiyanagi, O., K. Ishii & M. Endoh: Angiotensin II increases L-type Ca2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method. Pflugers Arch, 444, 107-16(2002) (Pubitemid 34499251)
81. Talukder, M. A. & M. Endoh: Pharmacological differentiation of synergistic contribution of L-type Ca2+ channels and Na+/H+ exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol, 355, 87-96(1997) (Pubitemid 27008457)
82. Cingolani, H. E., M. C. Villa-Abrille, M. Cornelli, A. Nolly, I. L. Ennis, C. Garciarena, A. M. Suburo, V. Torbidoni, M. V. Correa, M. C. Camilionde Hurtado & E. A. Aiello: The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension, 47, 727-34(2006) (Pubitemid 43740245)
83. Trongtorsak, P., T. O. Morgan & L. M. Delbridge: Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility. J Renin Angiotensin Aldosterone Syst, 4, 213-9(2003) (Pubitemid 38008172)
84. Capogrossi, M. C., T. Kaku, C. R. Filburn, D. J. Pelto, R. G. Hansford, H. A. Spurgeon & E. G. Lakatta: Phorbol ester and dioctanoylglycerol stimulate membrane association of protein kinase C and have a negative inotropic effect mediated by changes in cytosolic Ca2+ in adult rat cardiac myocytes. Circ Res, 66, 1143-55(1990) (Pubitemid 20126445)
85. Takeishi, Y., G. Chu, D. M. Kirkpatrick, Z. Li, H. Wakasaki, E. G. Kranias, G. L. King & R. A. Walsh: In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest, 102, 72-8(1998) (Pubitemid 28323832)
86. Chen, Y., R. Rajashree, Q. Liu & P. Hofmann: Acute p38 MAPK activation decreases force development in ventricular myocytes. Am J Physiol Heart Circ Physiol, 285, H2578-86 (2003) (Pubitemid 37443076)
87. Liao, P., S. Q. Wang, S. Wang, M. Zheng, M. Zheng, S. J. Zhang, H. Cheng, Y. Wang & R. P. Xiao: p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res, 90, 190-6(2002) (Pubitemid 34627088)
88. Vahebi, S., A. Ota, M. Li, C. M. Warren, P. P. de Tombe, Y. Wang & R. J. Solaro: p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ Res, 100, 408-15(2007)
89. Kranias, E. G. & D. M. Bers: Calcium and cardiomyopathies. Subcell Biochem, 45, 523-37(2007)
90. Liu, Y. H., D. Wang, N. E. Rhaleb, X. P. Yang, J. Xu, S. S. Sankey, A. E. Rudolph & O. A. Carretero: Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction. J Card Fail, 11, 74-81(2005) (Pubitemid 40215318)
91. Petit, F., D. Arnoult, L. Viollet & J. Estaquier: Intrinsic and extrinsic pathways signaling during HIV-1 mediated cell death. Biochimie, 85, 795-811(2003) (Pubitemid 37383799)
92. Porter, A. G., P. Ng & R. U. Janicke: Death substrates come alive. Bioessays, 19, 501-7(1997) (Pubitemid 27299498)
93. Thornberry, N. A. & Y. Lazebnik: Caspases: enemies within. Science, 281, 1312-6(1998) (Pubitemid 28406817)
94. Lorenzo, H. K., S. A. Susin, J. Penninger & G. Kroemer: Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ, 6, 516-24(1999) (Pubitemid 29292107)
95. Cregan, S. P., V. L. Dawson & R. S. Slack: Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene, 23, 2785-96(2004) (Pubitemid 38638842)
96. Lockshin, R. A. & Z. Zakeri: Caspase-independent cell death? Oncogene, 23, 2766-73(2004) (Pubitemid 38638840)
97. Anversa, P., A. Leri, C. A. Beltrami, S. Guerra & J. Kajstura: Myocyte death and growth in the failing heart. Lab Invest, 78, 767-86(1998) (Pubitemid 28347875)
98. Feuerstein, G. Z. & P. R. Young: Apoptosis in cardiac diseases: stress-and mitogen-activated signaling pathways. Cardiovasc Res, 45, 560-9(2000) (Pubitemid 30047122)
99. Narula, J., N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec. & B. A. Khaw: Apoptosis in myocytes in end-stage heart failure. N Engl J Med, 335, 1182-9(1996) (Pubitemid 26339772)
100. Anversa, P., J. Kajstura & G. Olivetti: Myocyte death in heart failure. Curr Opin Cardiol, 11, 245-51(1996) (Pubitemid 26238071)
101. Li, Y., G. Takemura, H. Okada, S. Miyata, H. Kanamori, R. Maruyama, M. Esaki, L. Li, A. Ogino, T. Ohno, T. Kondo, M. Nakagawa, S. Minatoguchi, T. Fujiwara & H. Fujiwara: ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart. Am J Physiol Heart Circ Physiol, 292, H946-53 (2007)
102. Feuerstein, G. Z.: Apoptosis in cardiac diseases - new opportunities for novel therapeutics for heart diseases. Cardiovasc Drugs Ther, 13, 289-94(1999) (Pubitemid 29427985)
103. Dzau, V. J.: Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens, 7, 933-6(1989) (Pubitemid 20106526)
104. Zheng, X., T. Zhang, H. Ding & C. Wang: Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine. Int J Cardiol, 51, 233-44(1995)
105. Cigola, E., J. Kajstura, B. Li, L. G. Meggs & P. Anversa: Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res, 231, 363-71(1997) (Pubitemid 27187989)
106. Kajstura, J., E. Cigola, A. Malhotra, P. Li, W. Cheng, L. G. Meggs & P. Anversa: Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol, 29, 859-70(1997) (Pubitemid 27196513)
107. Masaki, H., T. Kurihara, A. Yamaki, N. Inomata, Y. Nozawa, Y. Mori, S. Murasawa, K. Kizima, K. Maruyama, M. Horiuchi, V. J. Dzau, H. Takahashi, T. Iwasaka, M. Inada & H. Matsubara: Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest, 101, 527-35(1998) (Pubitemid 28084234)
108. Yamada, T., M. Horiuchi & V. J. Dzau: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A, 93, 156-60(1996) (Pubitemid 26038119)
109. Porrello ER, D. L., Thomas WG.: The Angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Frontiers in Bioscience, in press, (2008)
110. Miura, S. & S. S. Karnik: Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. Embo J, 19, 4026-35(2000) (Pubitemid 30608541)
111. Zhang, D., L. Yang, Z. Liu & S. Mi: Study on the effects of losartan on cardiomyocyte apoptosis and gene expression after ischemia and reperfusion in vivo in rats. J Tongji Med Univ, 20, 49-52(2000) (Pubitemid 33210419)
112. Nio, Y., H. Matsubara, S. Murasawa, M. Kanasaki & M. Inada: Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest, 95, 46-54(1995)
113. Griendling, K. K., P. Delafontaine, S. E. Rittenhouse, M. A. Gimbrone, Jr. & R. W. Alexander: Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem, 262, 14555-62(1987) (Pubitemid 17157360)
114. Lassegue, B., R. W. Alexander, G. Nickenig, M. Clark, T. J. Murphy & K. K. Griendling: Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol, 48, 601-9(1995)
115. Adachi, Y., Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, M. Nakanishi, Y. Nakagawa, K. Tanimoto, Y. Saitoh, S. Yasuno, S. Usami, M. Iwai, M. Horiuchi & K. Nakao: Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation, 107, 2406-8(2003) (Pubitemid 36605220)
116. Holtz, J.: Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction. Basic Res Cardiol, 93 Suppl 2, 92-100(1998) (Pubitemid 28498138)
117. Oishi, Y., R. Ozono, Y. Yano, Y. Teranishi, M. Akishita, M. Horiuchi, T. Oshima & M. Kambe: Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension, 41, 814-8(2003) (Pubitemid 36314596)
118. Jugdutt, B. I. & V. Menon: AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction. Mol Cell Biochem, 260, 111-8(2004) (Pubitemid 39127578)
119. Nickenig, G., J. Ostergren & H. Struijker-Boudier: Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers. J Renin Angiotensin Aldosterone Syst, 7 Suppl 1, S1-7 (2006) (Pubitemid 44383496)
120. Anavekar, N. S. & S. D. Solomon: Angiotensin II receptor blockade and ventricular remodelling. J Renin Angiotensin Aldosterone Syst, 6, 43-8(2005) (Pubitemid 40796848)
121. Bohm, M.: Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now? Am J Cardiol, 100, 38J-44J (2007)
122. Adams, J. W., A. L. Pagel, C. K. Means, D. Oksenberg, R. C. Armstrong & J. H. Brown: Cardiomyocyte apoptosis induced by Galphaq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res, 87, 1180-7(2000)
123. Kanamori, H., G. Takemura, Y. Li, H. Okada, R. Maruyama, T. Aoyama, S. Miyata, M. Esaki, A. Ogino, M. Nakagawa, H. Ushikoshi, M. Kawasaki, S. Minatoguchi & H. Fujiwara: Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan. Am J Physiol Heart Circ Physiol, 292, H2184-94 (2007) (Pubitemid 47084598)
124. Clerk, A., S. M. Cole, T. E. Cullingford, J. G. Harrison, M. Jormakka & D. M. Valks: Regulation of cardiac myocyte cell death. Pharmacol Ther, 97, 223-61(2003) doi not found. (Pubitemid 36167840)
125. Scheubel, R. J., B. Bartling, A. Simm, R. E. Silber, K. Drogaris, D. Darmer & J. Holtz: Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? J Am Coll Cardiol, 39, 481-8(2002) (Pubitemid 34117506)
126. Heidkamp, M. C., A. L. Bayer, J. L. Martin & A. M. Samarel: Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes. Circ Res, 89, 882-90(2001) (Pubitemid 34627893)
127. Orrenius, S., B. Zhivotovsky & P. Nicotera: Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol, 4, 552-65(2003) (Pubitemid 36773407)
128. Yoneda, T., K. Imaizumi, K. Oono, D. Yui, F. Gomi, T. Katayama & M. Tohyama: Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem, 276, 13935-40(2001)
129. Thor, H., P. Hartzell & S. Orrenius: Potentiation of oxidative cell injury in hepatocytes which have accumulated Ca2+. J Biol Chem, 259, 6612-5(1984) (Pubitemid 14108217)
130. Hajnoczky, G., L. D. Robb-Gaspers, M. B. Seitz & A. P. Thomas: Decoding of cytosolic calcium oscillations in the mitochondria. Cell, 82, 415-24(1995)
131. Zou, Y., H. Takano, H. Akazawa, T. Nagai, M. Mizukami & I. Komuro: Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy. Endocr J, 49, 1-13(2002) (Pubitemid 34194337)
132. Vila-Petroff, M., M. A. Salas, M. Said, C. A. Valverde, L. Sapia, E. Portiansky, R. J. Hajjar, E. G. Kranias, C. Mundina-Weilenmann & A. Mattiazzi: CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemiareperfusion injury. Cardiovasc Res, 73, 689-98(2007) (Pubitemid 46227351)
133. Zhang, T. & J. H. Brown: Role of Ca2+/calmodulindependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res, 63, 476-86(2004) (Pubitemid 38970192)
134. Zhu, W. Z., S. Q. Wang, K. Chakir, D. Yang, T. Zhang, J. H. Brown, E. Devic, B. K. Kobilka, H. Cheng & R. P. Xiao: Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest, 111, 617-25(2003) (Pubitemid 36278580)
135. Palomeque J, V. C., Salas MA, Mattiazzi A: CaMKII Activation is Involved in Angiotensin II-Mediated Cell Death. Circulation, 116, II-114-II-115 (2007)
136. Curran, J., M. J. Hinton, E. Rios, D. M. Bers & T. R. Shannon: Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res, 100, 391-8(2007)
137. Ai, X., J. W. Curran, T. R. Shannon, D. M. Bers & S. M. Pogwizd: Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res, 97, 1314-22(2005)
138. Chen, X., X. Zhang, H. Kubo, D. M. Harris, G. D. Mills, J. Moyer, R. Berretta, S. T. Potts, J. D. Marsh & S. R. Houser: Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrialdependent apoptosis in ventricular myocytes. Circ Res, 97, 1009-17(2005) (Pubitemid 41668914)
139. Caldiz, C. I., C. D. Garciarena, R. A. Dulce, L. P. Novaretto, A. M. Yeves, I. L. Ennis, H. E. Cingolani, G. Chiappe de Cingolani & N. G. Perez: Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium. J Physiol, 584, 895-905(2007) (Pubitemid 350031930)
140. Erickson, J. R., M. L. Joiner, X. Guan, W. Kutschke, J. Yang, C. V. Oddis, R. K. Bartlett, J. S. Lowe, S. E. O'Donnell, N. Aykin-Burns, M. C. Zimmerman, K. Zimmerman, A. J. Ham, R. M. Weiss, D. R. Spitz, M. A. Shea, R. J. Colbran, P. J. Mohler & M. E. Anderson: A dynamic pathway for calciumindependent activation of CaMKII by methionine oxidation. Cell, 133, 462-74(2008) (Pubitemid 351608692)
141. Palomeque J, S. L., Valverde CA, Velez Rueda JO, Salas MA, Mattiazzi A, Vila Petroff, M.: CaMKII mediates angiotensin II-induced cardiomyocytes apoptosis: Role of Ca2+, ROS and p38 MAPK. Journal of Molecular and Cellular Cardiology, 44, 764(2008)
142. Li, Z., J. Y. Ma, I. Kerr, S. Chakravarty, S. Dugar, G. Schreiner & A. A. Protter: Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury. Am J Physiol Heart Circ Physiol, 291, H1972-7 (2006) (Pubitemid 44497706)
143. Griffiths, E. J. & A. P. Halestrap: Mitochondrial nonspecific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J, 307(Pt 1), 93-8(1995)
144. Bendall, J. K., A. C. Cave, C. Heymes, N. Gall & A. M. Shah: Pivotal role of a gp91 (phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation, 105, 293-6(2002) (Pubitemid 34106175)
145. Johar, S., A. C. Cave, A. Narayanapanicker, D. J. Grieve & A. M. Shah: Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. Faseb J, 20, 1546-8(2006)
146. Matsushima, S., S. Kinugawa, T. Ide, H. Matsusaka, N. Inoue, Y. Ohta, T. Yokota, K. Sunagawa & H. Tsutsui: Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Am J Physiol Heart Circ Physiol, 291, H2237-45 (2006) (Pubitemid 44794216)
147. Ushio-Fukai, M., R. W. Alexander, M. Akers & K. K. Griendling: p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem, 273, 15022-9(1998) (Pubitemid 28272796)
148. Takeda, K., A. Matsuzawa, H. Nishitoh, K. Tobiume, S. Kishida, J. Ninomiya-Tsuji, K. Matsumoto & H. Ichijo: Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation. EMBO Rep, 5, 161-6(2004) (Pubitemid 38401195)